Fig. 2From: Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East ChinaTreatment outcomes of patients receiving different regimens. A Proportions of end-of-treatment success of patients receiving different regimens. B Culture conversion rate at month 6 of patients receiving different regimens. *p < 0.05; **p < 0.01Back to article page